Just Earth News | @justearthnews | 04 May 2021, 01:20 am Print
Pfizer-BioNTech Image: Pixabay
Washinton/Sputnik: The US Food and Drug Administration (FDA) is preparing to approve the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15, The New York Times reported, citing federal officials.
The authorization is expected to come early next week, the report said on Monday.
Pfizer announced several weeks ago that none of the adolescents who have received the vaccine during trials have contracted a symptomatic case of COVID-19.
However, plans to vaccinate teens and children, who rarely contract serious cases of the illness, have sparked debate, the report added, as many question whether excess US vaccines could be put to better use on adults in other countries.
- New study finds drinking coffee at night increases impulsive behaviour
- Aiming for 7,000 daily steps can reduce risk of chronic diseases, cognitive decline, and death: Study
- Scientists develop new mRNA vaccine to combat cancer
- Over 14 million infants remain unvaccinated in 2024: WHO
- New study shows vaccine campaigns cut deaths by nearly 60 per cent
